First-trimester prediction of preeclampsia in nulliparous women at low risk. - Wikidata - awgldk - TriplyDB

First-trimester prediction of preeclampsia in nulliparous women at low risk.

First-trimester prediction of preeclampsia in nulliparous women at low risk.

http://www.wikidata.org/entity/Q35988764

about

Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy If we know so much about preeclampsia, why haven't we cured the disease?Angiogenic factors in diagnosis, management, and research in preeclampsia.Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia Antenatal blood pressure for prediction of pre-eclampsia, preterm birth, and small for gestational age babies: development and validation in two general population cohorts Community health workers' knowledge and practice in relation to pre-eclampsia in Ogun State, Nigeria: an essential bridge to maternal survival.Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse population Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).Pregnancy, parturition and preeclampsia in women of African ancestry Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy.Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?Development and validation of a risk factor scoring system for first-trimester prediction of preeclampsia.The importance of early life in childhood obesity and related diseases: a report from the 2014 Gravida Strategic Summit Mid-trimester maternal ADAM12 levels differ according to fetal gender in pregnancies complicated by preeclampsia.Prevention and management of severe pre-eclampsia/eclampsia in Afghanistan.A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b).Preeclampsia and associated factors among pregnant women attending antenatal care in Dessie referral hospital, Northeast Ethiopia: a hospital-based study Combination of PAPPA, fhCGβ, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia Descriptive epidemiology of chronic hypertension, gestational hypertension, and preeclampsia in New York State, 1995-2004 The Effect of High Dose Folic Acid throughout Pregnancy on Homocysteine (Hcy) Concentration and Pre-Eclampsia: A Randomized Clinical Trial Predictor characteristics necessary for building a clinically useful risk prediction model: a simulation study.The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population.Prediction of Preeclampsia by First Trimester Combined Test and Simple Complete Blood Count Parameters.Genetic Risk Score for Essential Hypertension and Risk of Preeclampsia Follistatin-like 3 across gestation in preeclampsia and uncomplicated pregnancies among lean and obese women.The loss of sustained Ca(2+) signaling underlies suppressed endothelial nitric oxide production in preeclamptic pregnancies: implications for new therapy.A label-free selected reaction monitoring workflow identifies a subset of pregnancy specific glycoproteins as potential predictive markers of early-onset pre-eclampsia.Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia.Evidence of sexual dimorphism in the placental function with severe preeclampsia.The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes.The Level of Serum and Urinary Nephrin in Normal Pregnancy and Pregnancy with Subsequent Preeclampsia Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia.Predictive biomarkers of pre-eclampsia and effectiveness of preventative interventions for the disease.Clinical applications of biomarkers in preeclampsia.Pre-eclampsia: an update.Angiogenic biomarkers in pregnancy: defining maternal and fetal health.First-trimester screening for preeclampsia: impact of maternal parity on modeling and screening effectiveness.Preeclampsia: Syndrome or Disease?Availability of COLLECT, a database for pregnancy and placental research studies worldwide.

P2860

Q26781355-C0DF8D86-B625-4EB2-9CE4-D33F341FF421 Q26861380-D9254E2F-233B-4685-AE3C-14E7CC69FF36 Q27009441-F2882970-79E0-46A0-A8BF-B9C2FFBC41CB Q27692060-7B8C60DF-7754-4D82-9A63-52435040FECF Q28081459-816D503D-33EC-4059-8C3D-BACA6633B171 Q28607419-FC666CB3-0533-47D5-B0A8-384897720711 Q30820019-CE8EB533-4345-4D0D-89CF-C1B0A78709AC Q33406987-D6AA76C8-3C6A-44A0-BFFA-6206E4167570 Q33579089-95391B08-D108-4F1C-9DD3-D58339CFDEBB Q33715526-0FA4795B-DDB0-4AA3-B382-2DD6D8A890BA Q33826353-EA248F12-D724-46EF-95F8-50573AA06BD7 Q33923716-12442E5E-3FAA-4137-B414-58D8762E0140 Q34289412-0164B790-A29A-436F-AC1A-07EA688B48D9 Q34629295-C342FA35-5A0C-4ADA-A5B9-27C22582AAD9 Q34876147-E791CBFA-6C0A-444C-B5A3-98A5295E7F02 Q35016027-29D0A6F7-526A-4443-8134-8703DEFFCFB1 Q35287430-C6D101D1-A3BC-44D0-BF64-317FC607155E Q35358822-69689490-B51D-4C4C-8ABD-96A60BB47D4A Q35747044-684D727D-813A-46CC-8810-8A5028487640 Q35849525-B63ED0AC-04C9-4461-8871-438853A2F91F Q36014095-AA5737E3-12AA-4B4D-AD37-C8914B75CE42 Q36140001-D06154B8-12FA-4952-9CD0-DDDCF0C19CAA Q36253829-DDFA871A-349D-4772-96D5-74E15B71EDAD Q36343649-3941FC0B-6E46-4B36-B940-54F3DB71C5E7 Q36408977-2F9496BA-58D0-48EC-A603-79CB92091E80 Q36742604-F04C5B77-AD39-4EB0-B7C2-CA6C4A56FDDF Q37234812-33176BAD-EC25-44A3-B8E6-1613D89EAB97 Q37289388-6DE99F7F-1D60-4A27-91EB-A326D1911053 Q37348561-6EE59975-493E-4058-9596-431A1DFBD645 Q37404418-D9C458EA-D7A9-4BDF-A92C-6A67B9EF362B Q37489857-E455E625-B9D3-43FA-BF6D-71DA635455CF Q37622169-23DB89E1-C6E3-4AA7-9C1A-22B040B94C79 Q37711864-E560AB98-2887-4388-9615-39440A7C1AA3 Q38207099-34298ACE-3E2F-4694-94EE-982BA566A6C5 Q38209381-8F33FD61-17A8-45B8-9342-1E8ECAB466E4 Q38219228-F9C87907-22DA-4846-9FBE-CC991BB445B7 Q38370968-D6EA1EE5-9C25-4D82-A72A-037D8F0F8A58 Q38432783-39D24019-D905-4232-8FCF-16FC9571443C Q38585309-1CAB1CD1-6074-4FF9-9EB3-1646A8C52335 Q38597467-6618D802-5457-4A26-BA15-98ADE7C77544

P2860

First-trimester prediction of preeclampsia in nulliparous women at low risk.

http://www.wikidata.org/entity/Q35988764

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

First-trimester prediction of preeclampsia in nulliparous women at low risk.

@ast

First-trimester prediction of preeclampsia in nulliparous women at low risk.

@en

type

label

First-trimester prediction of preeclampsia in nulliparous women at low risk.

@ast

First-trimester prediction of preeclampsia in nulliparous women at low risk.

@en

prefLabel

First-trimester prediction of preeclampsia in nulliparous women at low risk.

@ast

First-trimester prediction of preeclampsia in nulliparous women at low risk.

@en

P1433

Q35988764-888D0682-399D-464E-8A20-668F9D66DA1B

P1476

Q35988764-8A1BFB52-CA84-4BDD-A498-798DFA694710

P2093

Q35988764-059B1E8B-BBEF-4A2F-8364-47570B023F03

Q35988764-15F71B4B-9CD5-4F8E-93B8-F527F8D1D108

Q35988764-20791F44-0D6C-4A07-86B5-A801CAEEBAEE

Q35988764-2B174364-10E4-4000-81C5-A9A04D9EFBCE

Q35988764-525B99E2-7830-4756-922E-036D11092651

Q35988764-624C0E63-7DE3-4B3D-BB2A-313930E370E5

Q35988764-726814B2-F802-4F2D-A7A5-C15257077A7C

Q35988764-90BD54FF-B3DB-46FE-9246-CE8599C53E72

Q35988764-A38E90C5-579C-47BC-A652-69AA1C9A7D67

Q35988764-AD810F2F-E0E1-452F-8CDB-BEE22C434609

P2860

Q35988764-199E0D29-86D4-4C5C-A589-8959720C567D

Q35988764-1C374C45-B3CC-4381-9795-28DC4426C059

Q35988764-2E3CC5F4-27D8-4549-8D34-2D5B4CCB8C2D

Q35988764-3FDAF17E-AC19-4AFC-926C-89449A1A9878

Q35988764-42FB064B-4728-4443-983A-C5AA0F0BA145

Q35988764-46D699DC-F84D-4928-8383-3927D74F6311

Q35988764-595EBDBC-C0FC-401E-830F-621D272FC0FE

Q35988764-5D7F9E86-20D7-4162-906F-B8B522531549

Q35988764-65920A41-B62F-45BD-B0F2-05AC5B10A547

Q35988764-92BF7CE6-71FF-45BF-BE93-84BAD96E8DBD

P304

Q35988764-2A1A38FC-197B-49CB-8332-5B7176F5170F

P31

Q35988764-13FCE82A-87B5-4265-A97B-ABF5D5B92CBE

P356

Q35988764-6C794997-DFB8-4726-8285-6C8FEA3879B8

P407

Q35988764-8FD80345-B1CC-4217-B3EA-2A3BCD46C6C1

P433

Q35988764-1C2D3BB3-D962-40C2-92B3-BBF8611522D9

P478

Q35988764-D9D9C387-9DF7-472F-B0B5-55D008F62404

P50

Q35988764-08AFCE69-3F40-40C4-8F7E-FBF27B73CB57

Q35988764-52E734DB-ADB5-4920-8D53-A0C676D03463

Q35988764-53627036-F2F6-4D22-AA81-D7AF60927C33

Q35988764-6EF1294B-0997-40E4-BAAC-15CC30F1F86E

Q35988764-9F6386CE-ACF5-47AD-B012-8419260D26B3

P577

Q35988764-260B06C5-C796-4449-AB51-21DDA9C68126

P698

Q35988764-8E4EAA47-49AD-4B6C-8F72-8DF967DEAF7B

P921

Q35988764-74E9EDC5-FAE6-4465-B42C-51DCFC7F7422

P932

Q35988764-6275ACB6-2C52-4295-8B64-6350F41D9685

P356

AOG.0B013E3182571669

P1433

Obstetrics and Gynecology

P1476

First-trimester prediction of preeclampsia in nulliparous women at low risk.

@en

P2093

Anthony Sciscione

http://www.w3.org/2001/XMLSchema#string

Brian M Mercer

http://www.w3.org/2001/XMLSchema#string

Garland D Anderson

http://www.w3.org/2001/XMLSchema#string

George Saade

http://www.w3.org/2001/XMLSchema#string

James M Roberts

http://www.w3.org/2001/XMLSchema#string

Jay D Iams

http://www.w3.org/2001/XMLSchema#string

John C Hauth

http://www.w3.org/2001/XMLSchema#string

John M Thorp

http://www.w3.org/2001/XMLSchema#string

Jorge E Tolosa

http://www.w3.org/2001/XMLSchema#string

Leslie Myatt

http://www.w3.org/2001/XMLSchema#string

P2860

Immunohistochemical demonstration of pregnancy-associated plasma protein A (PAPP-A) in the syncytiotrophoblast of the normal placenta at different gestational ages

Purification and characterization of two new soluble placental tissue proteins (PP13 and PP17)

Vitamins C and E to prevent complications of pregnancy-associated hypertension

Prediction of preeclampsia.

Role of the IGF system in trophoblast invasion and pre-eclampsia.

The familial factor in toxemia of pregnancy.

Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies.

Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome.

First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.

Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort.

P304

1234-1242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/AOG.0B013E3182571669

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Alan M. Peaceman

Michael W. Varner

Catherine Y Spong

Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22617589

http://www.w3.org/2001/XMLSchema#string

P921

P932

3360523

http://www.w3.org/2001/XMLSchema#string